US FDA orders new eye risk warnings for Ozempic, Zepbound
· cnn.com · popularity 48/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at cnn.com →
Summary
Reuters — The US Food and Drug Administration on Monday informed patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. The FDA said it is requiring GLP-1 drugs such as Eli Lilly’s Mounjaro and …
Found in: CNN, Health. Rating basis: single outlet; outlet tier 5; 2 feeds; listed 2 times; feed position 2.